Evidence map›Paper›PMID 39565860›Full record

ArticleScience advances2024

Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection.

Jessica L McCord, John Y S Han, Ross E Staudt, Nancy J Philp, Christopher M Snyder

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica L McCordDepartment of Microbiology and Immunology, Jefferson Center for Vaccines and Pandemic Preparedness, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0009-0001-6424-9951
John Y S HanDepartment of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0003-4200-5128
Ross E StaudtDepartment of Microbiology and Immunology, Jefferson Center for Vaccines and Pandemic Preparedness, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0003-1439-7937
Nancy J PhilpDepartment of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0001-7028-0448
Christopher M SnyderDepartment of Microbiology and Immunology, Jefferson Center for Vaccines and Pandemic Preparedness, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0003-1370-7198

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Andrew Chapman · 1995 to 2026
$94.8M
RPE LACTATE TRANSPORTERS--A ROLE IN RETINAL SURVIVALR01EY012042 · NEI · THOMAS JEFFERSON UNIVERSITY · PI PHILP, NANCY JEAN · 1998 to 2018
$5.7M
Recycling of Metabolites from Ingested Outer Segments Supports Visual FunctionR01EY026525 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BOESZE-BATTAGLIA, KATHLEEN, PHILP, NANCY JEAN · 2016 to 2023
$3.4M
T cell control of MCMV and tissue-localized immune suppressionR01AI146235 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SNYDER, CHRISTOPHER M · 2020 to 2024
$2.7M
Training grant on Vaccines and Immunotherapies for Infectious Diseases and CancerT32AI134646 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SCHNELL, MATTHIAS JOHANNES, SIGAL, LUIS J · 2018 to 2022
$1.1M
RPE Lactate Transporters: A Role in Retinal SurvivalR56EY012042 · NEI · THOMAS JEFFERSON UNIVERSITY · PI PHILP, NANCY JEAN · 2009 to 2009
$386k
An animal model for cytomegalovirus-induced pathology in the developing retinaR03AI169437 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SNYDER, CHRISTOPHER M · 2022 to 2023
$156k
NCI NIH HHS P30 CA056036NEI NIH HHS R01 EY012042NEI NIH HHS R01 EY026525NEI NIH HHS R56 EY012042NIAID NIH HHS R01 AI146235NIAID NIH HHS R03 AI169437NIAID NIH HHS T32 AI134646
6 · The paper itself

Abstract

Human cytomegalovirus (CMV) causes a common congenital infection leading to long-term neurological impairments including brain, cochlear, and ocular pathology. Infection of newborn mice with murine (M)CMV is an established model of neuropathology caused by congenital CMV infection, with recent work suggesting that brain pathology may be driven by immune responses. In the eye, however, CMV retinitis is thought to result from virus-driven necrosis in the absence of T cell responses. We found that MCMV infection of newborn mice recapitulates human eye disease after congenital CMV infection, including focal chorioretinitis, inflamed vasculature, and disrupted blood-retinal barriers. Moreover, infection drove extensive T cell infiltration of the retina and marked gliosis. Blocking immune responses generally, or via targeting the chemokine receptor CXCR3, did not exacerbate retinal disease but instead prevented pathology despite retinal MCMV infection. Thus, our data establish this model for studies of congenital retinal disease and show that the immune system drives pathology in the neonatal eye after MCMV infection.

Indexed as

Animals, NewbornChorioretinitisMuromegalovirusRetinaAnimalsCytomegalovirus InfectionsCytomegalovirus RetinitisDisease Models, AnimalHumansMiceReceptors, CXCR3T-LymphocytesCxcr3 protein, mouseReceptors, CXCR3

Identifiers

PMID39565860
PMCPMC11578184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.